Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the KSA.
Campus
Campus

The role of the patient in Achieving LDL-C Target

Watch Prof. Lale Tokgozoglu, president of the European Atherosclerosis Association providing insights on how to get the patient to the goals that are recommended in the guidelines and the need to keep the patient there.

Related articles
Lp(a) and PCSK9 inhibition in nominally controlled LDL-C patients

Lp(a) and PCSK9 inhibition in nominally controlled LDL-C patients

Read article
Lp(a) as ASCVD risk factor

Lp(a) as ASCVD risk factor

Read article
Dyslipidemia performance of 2016 2019 and 2021 ESC Dyslipidemia guidelines

Dyslipidemia performance of 2016 2019 and 2021 ESC Dyslipidemia guidelines

Read article
MAT-KW-2200129/v2/Mar 2024